Bliede Van den Broeck

¹⁸F-AlF-NOTA-Octreotide Outperforms⁶⁸Ga-DOTATATE/NOC PET in Neuroendocrine Tumor Patients: Results from a Prospective, Multicenter Study

Elin Pauwels, Frederik Cleeren, Térence Tshibangu et al. · Journal of Nuclear Medicine · 2022 · 70 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Noise reduction using a Bayesian penalized-likelihood reconstruction algorithm on a time-of-flight PET-CT scanner

Paulo Rauli Rafeson De Vasconcelos Caribé, Michel Koole, Yves D’Asseler et al. · EJNMMI Physics · 2019 · 50 citations · Full text

Medicine, Nuclear Medicine, Radiology +17

Shallow-depth sequencing of cell-free DNA for Hodgkin and diffuse large B-cell lymphoma (differential) diagnosis: a standardized approach with underappreciated potential

Lennart Raman, Malaïka Van Der Linden, Ciel De Vriendt et al. · Haematologica · 2020 · 27 citations · Full text

Medicine, Hematology, Oncology +15

Clinical impact of using [ <scp> ¹⁸ F </scp> ] <scp>AlF</scp> ‐ <scp>NOTA</scp> ‐octreotide <scp>PET</scp> / <scp>CT</scp> instead of [ <scp> ⁶⁸ Ga </scp> ]Ga‐ <scp>DOTA</scp> ‐ <scp>SSA PET</scp> / <scp>CT</scp> : Secondary endpoint analysis of a multicenter, prospective trial

Hannes Leupe, Elin Pauwels, Timon Vandamme et al. · Journal of Neuroendocrinology · 2024 · 10 citations · Full text

Medicine, Nuclear Medicine, Oncology +17